1. Casillas J, Ross J, Keohan ML, Bleyer A, Malogolowkin M (2006) Chapter 7: Soft tissue sarcomas. In: Bleyer A, OLMBarr R, Ries LAG (eds) Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975–2000. National Cancer Institute, Bethesda, NIH, 2006
2. Mascarenhas L, Siegel S, Spector L, Arndt C, Femino D, Malogowkin M (2006) Malignant bone tumors. In: Bleyer A, OLM Barr R, Ries LAG (eds) Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975–2000. National Cancer Institute, Bethesda, NIH Pub. No. 06-5767, 2006
3. Weiss AR, Lyden ER, Anderson JR et al (2013) Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: a report from the Children’s Oncology Group Soft Tissue Sarcoma Committee. J Clin Oncol 31:3226–3232
4. Quartuccio N, Cistaro A (2014) Primary bone tumors. In: Cistaro A (ed) Atlas of PET/CT in pediatric patients. Springer, Milan, pp 67–86
5. Tsiflikas I, Thomas C, Ketelsen D et al (2014) High-pitch computed tomography of the lung in pediatric patients: an intraindividual comparison of image quality and radiation dose to conventional 64-MDCT. Rofo 186:585–590